JPH0542432B2 - - Google Patents

Info

Publication number
JPH0542432B2
JPH0542432B2 JP59164160A JP16416084A JPH0542432B2 JP H0542432 B2 JPH0542432 B2 JP H0542432B2 JP 59164160 A JP59164160 A JP 59164160A JP 16416084 A JP16416084 A JP 16416084A JP H0542432 B2 JPH0542432 B2 JP H0542432B2
Authority
JP
Japan
Prior art keywords
phenyl group
substituted phenyl
phenyl
group
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59164160A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6051176A (ja
Inventor
Kazuo Matsumoto
Yoshiro Iwazawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Tanabe Seiyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co Ltd filed Critical Tanabe Seiyaku Co Ltd
Publication of JPS6051176A publication Critical patent/JPS6051176A/ja
Publication of JPH0542432B2 publication Critical patent/JPH0542432B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP59164160A 1983-08-12 1984-08-03 新規イミダゾリン誘導体及びその製法 Granted JPS6051176A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8321719 1983-08-12
GB08321719A GB2144738A (en) 1983-08-12 1983-08-12 Imidazolines

Publications (2)

Publication Number Publication Date
JPS6051176A JPS6051176A (ja) 1985-03-22
JPH0542432B2 true JPH0542432B2 (https=) 1993-06-28

Family

ID=10547197

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59164160A Granted JPS6051176A (ja) 1983-08-12 1984-08-03 新規イミダゾリン誘導体及びその製法

Country Status (2)

Country Link
JP (1) JPS6051176A (https=)
GB (1) GB2144738A (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07111812B2 (ja) * 1987-06-15 1995-11-29 三菱電機株式会社 デイジタル再生装置
JPH0748285B2 (ja) * 1986-10-24 1995-05-24 三菱電機株式会社 ディジタル再生装置

Also Published As

Publication number Publication date
GB8321719D0 (en) 1983-09-14
GB2144738A (en) 1985-03-13
JPS6051176A (ja) 1985-03-22

Similar Documents

Publication Publication Date Title
RU2351588C2 (ru) Производные n-фенил(пиперидин-2-ил)метил-бензамида и их применение в терапии
JP4316794B2 (ja) イソキノリン誘導体及び医薬
WO1988002365A1 (fr) Derives d'amines cycliques
EA007225B1 (ru) Производные n-[фенил(пиперидин-2-ил)метил]бензамида и их применение в терапии
JPWO1999020620A1 (ja) イソキノリン誘導体及び医薬
HU202211B (en) Process for producing new imidazoline derivatives and pharmaceutical compositions containing them as active components
JPH0240657B2 (ja) 3*44jihidorokarubosuchirirujudotai
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
JPH0832703B2 (ja) ベンゾイミダゾールの新規誘導体、それらの製法、及びそれらの医薬用途
JPH05140108A (ja) ピリジニルピペラジン誘導体
JPS6226271A (ja) キノリルグリシンアミド誘導体、その製法及び該化合物を含有する向精神薬
JPH02178263A (ja) アザアズレン誘導体、その製造法およびそれを有効成分とする抗アレルギー剤および抗炎症剤
JPH0291052A (ja) 置換アミン類
SU990761A1 (ru) Гидрохлориды производных 4-дифенилметилен-1-гидроксибензилпиперидина,обладающие свойством улучшать кровообращение
RU2236407C2 (ru) Производные пиримидина
WO2005100341A1 (ja) ２－アミノピリミジン誘導体
JPH0542432B2 (https=)
WO1998014444A1 (fr) Derives de n-(benzothiazol-2-yl)piperidine-1-ethanamine, leur preparation et leur application en therapeutique
CN109180679B (zh) 一类N-取代吡唑并[3,4-d]嘧啶酮类化合物及其制备方法和应用
JPS63185948A (ja) 置換アミノプロピオンアミドおよびその製造方法
RU2178790C2 (ru) Производные дибензо[d, g][1,3]диоксоцина и дибензо-[d,g][1,3,6]диоксазоцина, способ их получения, фармацевтическая композиция на их основе и способ лечения нейрогенного воспаления, нейропатии и ревматоидного артрита
JP2001511798A (ja) オキシド−スクアレンシクラーゼ抑制剤として有用な複素環化合物
JPH069402A (ja) 抗潰瘍剤
US4612317A (en) Tetrahydro-β-carboline dithioic acid derivatives and treatment of liver diseases
JPH11509520A (ja) 鎮痛特性を有する新規のｎ−アセチル化４−ヒドロキシフェニルアミン誘導体及びそれを含む薬理組成物